1144199

Inopak Ltd — FEI 1000122232

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 18, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ringwood, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
136121 CFR 211.100(a)Absence of Written Procedures
139621 CFR 211.42(c)(2)Rejected Material Area
180221 CFR 211.84(b)Representative Samples
180921 CFR 211.160(a)Following/documenting laboratory controls
360321 CFR 211.160(b)Scientifically sound laboratory controls